FSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended June 2020)

Published on: 24 June 2020

File size: 1206kb PDF

File type: Current Clinical Guidance

Author: FSRH Clinical Effectiveness Unit

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

Your download should start automatically. If not download directly.